MKL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.157000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.892600E-01
Normal-vs-Stage2
8.201000E-01
Normal-vs-Stage3
1.861980E-01
Normal-vs-Stage4
8.035600E-01
Stage1-vs-Stage2
3.248000E-01
Stage1-vs-Stage3
8.719900E-02
Stage1-vs-Stage4
4.661600E-01
Stage2-vs-Stage3
2.568200E-01
Stage2-vs-Stage4
9.512000E-01
Stage3-vs-Stage4
2.313400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.929000E-01
Normal-vs-AfricanAmerican
5.742000E-01
Normal-vs-Asian
1.549430E-01
Caucasian-vs-AfricanAmerican
1.205830E-01
Caucasian-vs-Asian
8.182000E-02
AfricanAmerican-vs-Asian
2.271900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.415800E-01
Normal-vs-Female
9.060800E-01
Male-vs-Female
4.543000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.721200E-01
Normal-vs-Age(41-60Yrs)
8.681200E-01
Normal-vs-Age(61-80Yrs)
6.608000E-01
Normal-vs-Age(81-100Yrs)
2.388400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.437000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.874400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.893450E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.666100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.096080E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.207400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.461600E-01
Normal-vs-Daily Drinker
2.872800E-01
Normal-vs-Weekly Drinker
1.380050E-01
Normal-vs-Occasional Drinker
6.479200E-01
Normal-vs-Social Drinker
8.915400E-01
Non Drinker-vs-Daily Drinker
3.954800E-01
Non Drinker-vs-Weekly Drinker
1.773430E-01
Non Drinker-vs-Occasional Drinker
7.461600E-01
Non Drinker-vs-Social Drinker
3.868800E-01
Daily Drinker-vs-Weekly Drinker
5.204400E-01
Daily Drinker-vs-Occasional Drinker
2.638600E-01
Daily Drinker-vs-Social Drinker
2.311200E-01
Weekly Drinker-vs-Occasional Drinker
1.042150E-01
Weekly Drinker-vs-Social Drinker
1.476200E-01
Occasional Drinker-vs-Social Drinker
4.757800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.177150E-01
Normal-vs-Grade 2
1.278240E-01
Normal-vs-Grade 3
2.596300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.067800E-01
Grade 1-vs-Grade 3
9.388000E-01
Grade 1-vs-Grade 4
1.177150E-01
Grade 2-vs-Grade 3
7.995600E-01
Grade 2-vs-Grade 4
1.278240E-01
Grade 3-vs-Grade 4
2.596300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.979200E-01
Normal-vs-NonDiabetic
6.798800E-01
Diabetic-vs-NonDiabetic
6.782200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.184400E-01
Normal-vs-NoPancreatitis
7.033600E-01
Pancreatitis-vs-NoPancreatitis
1.578600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.471200E-01
Normal-vs-N1
8.706400E-01
N0-vs-N1
4.919200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.151000E-01
Normal-vs-TP53-NonMutant
9.475600E-01
TP53-Mutant-vs-TP53-NonMutant
1.276110E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
